| 摘要 |
<p>The present invention relates generally to lysosomal storage disorders and to diagnostic agents for their detection in humans and other animals. More particularly, the present invention is directed to the uses of the LSD markers Lamp-1, Lamp-2, Limp-II, 4-sulphatase, acid phosphatase (ACP), β-hexosaminidase or α-mannosidase, amongst others as diagnotic agents for the detection of many lysosomal storage disorders.</p> |
